source
- BridgeBio Oncology appoints CSO Pedro Beltran as CEO, makes Neil Kumar executive chairmanBridgeBio Oncology Therapeutics announced a leadership reshuffle aimed at strengthening its focus on KRAS-driven cancer programs. The company is replacing CEO Eli Wallace with its chief scientific…
- Pharma-backed petition urges FDA to change policy on public release of drug rejection lettersA law firm representing an unnamed pharmaceutical company has filed a petition asking the FDA to revise its new practice of publishing partially redacted drug rejection letters. The petition argue…